Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463042 · ClinicalTrials.gov registry record · NA
Intermittent Hypoxia and Balance Control
A NA study of Intermittent Hypoxia and Normoxia, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT05463042 is a NA study of Intermittent Hypoxia and Normoxia that has completed, run by University of Texas at Austin. The registered enrollment target is 3 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05463042, a NA study of Intermittent Hypoxia and Normoxia, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the effect of acute mild intermittent hypoxia on ankle plantarflexor muscle output during balance regulation and walking in younger and older adults. Fifteen younger adults and 15 older adults will be recruited to participate in the cross-over design study that requires 2 visits (at least 1-week apart). Participants will be pseudo-randomly assigned to receive either intermittent hypoxia or sham during the first visit, and then switch over to receive sham or intermittent hypoxia during the 2nd visit. Muscle activation patterns and kinetic and kinematics during standing and walking will be recorded before and after the intermittent hypoxia/sham. It is hypothesized that compared to the sham condition, both younger and older participants will show greater increases in ankle plantarflexor muscle activation during gait and balance assessments following intermittent hypoxia.
Conditions Studied
Interventions
- BEHAVIORAL Intermittent Hypoxia
- BEHAVIORAL Normoxia (sham)
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463042
The ClinicalTrials.gov registry entry for NCT05463042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Intermittent Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Hypoxia is the first listed.
NCT05463042 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05463042 about?
NCT05463042 is a clinical study titled "Intermittent Hypoxia and Balance Control". This study aims to determine the effect of acute mild intermittent hypoxia on ankle plantarflexor muscle output during balance regulation and walking in younger and older adults. Fifteen younger adults and 15 older adults will be recruited to participate in the cross-over design study that requires ...
What is the current status of trial NCT05463042?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2022-09-01. Estimated completion is 2023-08-21.
What conditions does trial NCT05463042 study?
This clinical trial studies the following conditions: Intermittent Hypoxia, Normoxia.
What interventions are being tested in trial NCT05463042?
The interventions under investigation include: Intermittent Hypoxia (BEHAVIORAL), Normoxia (sham) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05463042?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463042 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.